VANCOUVER, BC – NervGen Pharma Corp. (“NervGen” or the “Company”) (TSXV: NGEN) is pleased to announce the closing of its previously announced public offering (the “Offering”) including the full exercise of the underwriters’… Read More
In a time where medical assistance is critical, Getinge donates extensive medical equipment to Ukraine. The donation, made in collaboration with the Ministry of Health Ukraine, includes a significant number… Read More
With the introduction of the SUPR, Getinge again exploits its experience in bioreactor design resulting in a single-use bioreactor system for pilot and GMP manufacturing applications, completely scalable from its’… Read More
VANCOUVER, BC – Filament Health Corp. (OTCQB:FLHLF) (Cboe CA:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development company, announced the appointment of Michael Messinger, CPA, to its Board of… Read More
Announces next-generation COVID-19 vaccine candidate as fourth respiratory vaccine to successfully meet its Phase 3 endpoints Expects two more Phase 3 readouts in 2024, including combination vaccine against flu and… Read More
